Showing results (1-10 of 436) with videos related to
Sort By:
Pageof 44
Lymphatic Research and Biology|September 19, 2012
The role of sphingosine-1-phosphate in breast cancer tumor-induced lymphangiogenesisTomoyoshi Aoyagi, Masayuki Nagahashi, Akimitsu Yamada, et al.World Journal of Gastroenterology|November 17, 2012
Inverted Meckel's diverticulum as a cause of occult lower gastrointestinal hemorrhageOmar M Rashid, Joseph K Ku, Masayuki Nagahashi, et al.Future Oncology (London, England)|April 21, 2012
Bevacizumab and breast cancer: what does the future hold?Christina E Stevenson, Masayuki Nagahashi, Subramaniam Ramachandran, et al.Heliyon|January 6, 2017
Sphingosine-1-phosphate in the lymphatic fluid determined by novel methodsMasayuki Nagahashi, Akimitsu Yamada, Tomoyoshi Aoyagi, et al.Journal of Surgery and Science|July 29, 2014
Intestinal Co-infection of Tuberculosis and CMV can Cause Massive Lower GI Bleeding in a Patient with HIVMasayuki Nagahashi, Tomoyoshi Aoyagi, Akimitsu Yamada, et al.The Journal of Surgical Research|May 27, 2015
Development of a metastatic murine colon cancer modelKrista P Terracina, Tomoyoshi Aoyagi, Wei-Ching Huang, et al.The Journal of Surgical Research|August 28, 2016
Operation with less adjuvant therapy for elderly breast cancerAkimitsu Yamada, Kazutaka Narui, Sadatoshi Sugae, et al.NPJ Breast Cancer|June 6, 2026
The clinical relevance of apocrine morphology in breast cancer depends on the estrogen receptor statusKei Kawashima, Masanori Oshi, Akimitsu Yamada, et al.American Journal of Cancer Research|July 11, 2022
The clinical relevance of unfolded protein response signaling in breast cancerMasanori Oshi, Arya Mariam Roy, Shipra Gandhi, et al.Annals of Surgical Oncology|June 21, 2025
Activated Hippo Pathway is Associated with a Worse Response to Trastuzumab and Worse Survival in HER2-Positive Breast CancerMasanori Oshi, Farhad Ghasemi, Akimitsu Yamada, et al.Pageof 44